Search
for
Sort by
Research 391–420 of 1000+
- Lasers and Energy-Based Devices in Men
- An audit of dermatoses at Baqai Institute of Skin Diseases, Karachi
- Modifiable Lifestyle and Behavioral Factors Associated With Disease Severity in Androgenetic Alopecia: A Propensity Score–Matched Cross‐Sectional Study
- Mult-trait analysis of GWAS - Perceived youtfulness - UKBB
- Finasteride: suicidality or psychological adverse events
- Androgens
- Clinical use of 5α-reductase inhibitors
- Prevalence of rs1998076 and Its Association with Androgenetic Alopecia in Indonesian Population: A Pilot Study
- Menopause in Women, Andropause in Men: Myth, Reality, and Management
- Treatments of hereditary hair loss (alopecia)
- Effects of Abuse of Anabolic Androgenic Steroids on Iraqi Athletes
- Transsexualism
- The manosphere and men's health: unpacking the links between online communities, body dysmorphia and erectile dysfunction
- Roles of steroid receptors in the lung and COVID-19
- The Rotterdam Study: 2018 update on objectives, design and main results
- DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
- The Hair Follicle as an Estrogen Target and Source
- Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors
- Finasteride
- `A Dubious Equality': Men, Women and Cosmetic Surgery
- Dermatologic care of the transgender patient
- Hypertrichosis induced by latanoprost
- Allopregnanolone in the bed nucleus of the stria terminalis modulates contextual fear in rats
- Use of Hair Products Containing Hormone or Placenta by US Military Personnel
- Meta-Analysis of Randomized Clinical Trials of Finasteride
- Reliability of the pattern hair loss classifications: A comparison of the basic and specific and Norwood–Hamilton classifications
- Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance
- Nonsurgical Therapy for Hair Loss
- Dermatological aspects of synthetic cannabinoid addiction
- Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer